Trials / Completed
CompletedNCT00002431
The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infected Patients
A Multi-Center Trial to Evaluate the Safety and Effectiveness of Peridex Dosed Twice or Three Times Daily for Preventing or Delaying the Occurrence of Lesions Due to Oral Candidiasis in HIV-Positive Individuals
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Procter and Gamble · Industry
- Sex
- All
- Age
- 13 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and effectiveness of Peridex (an oral rinse containing chlorhexidine gluconate) for preventing the occurrence of clinically-evident microbiologically-documented oral candidiasis in HIV-positive patients, who are at risk of the disease based on previous history of candidiasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chlorhexidine gluconate |
Timeline
- First posted
- 2001-08-31
- Last updated
- 2005-06-24
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00002431. Inclusion in this directory is not an endorsement.